Inactive Instrument

Isodiol International Inc. Stock Canadian Securities Exchange

Equities

ISOL

CA46500L2003

Pharmaceuticals

Sales 2018 19.14M 26.16M Sales 2019 22.25M 30.42M Capitalization 49.96M 68.3M
Net income 2018 -36M -49.22M Net income 2019 -126M -172M EV / Sales 2018 12.6 x
Net cash position 2018 15.55M 21.26M Net Debt 2019 5.22M 7.14M EV / Sales 2019 2.48 x
P/E ratio 2018
-4.94 x
P/E ratio 2019
-0.37 x
Employees -
Yield 2018 *
-
Yield 2019
-
Free-Float 100%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 17-05-23
Director/Board Member - 18-08-29
Corporate Officer/Principal - 19-02-13
Members of the board TitleAgeSince
Chief Executive Officer - 17-05-23
Director/Board Member - 18-08-29
Director/Board Member - 18-11-20
More insiders
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nano-technology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
More about the company